Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 1, 2009
Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness
Andrea J Rapkin, Sharon A Winer
The Journal of Reproductive Medicine
|
June 1, 2006
Premenstrual disorders: prevalence, etiology and impact
Sharon A Winer, Andrea J Rapkin
Expert Opinion on Pharmacotherapy
|
May 3, 2007
Drospirenone: a novel progestin
Andrea J Rapkin, Sharon A Winer
Menopause (New York, N.Y.)
|
April 26, 2013
Effect of hormone therapy on breast epithelial cell proliferation
Frank Z Stanczyk, Sharon A Winer
Expert Opinion on Pharmacotherapy
|
January 29, 2008
The pharmacologic management of premenstrual dysphoric disorder
Andrea J Rapkin, Sharon A Winer
Women'S Health (London, England)
|
October 7, 2009
Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder
Andrea J Rapkin, Michelle McDonald, Sharon A Winer
Menopause (New York, N.Y.)
|
May 27, 2025
Letters to the Editor
Frank Z Stanczyk, Sharon A Winer, Donna Shoupe
Drugs of Today (Barcelona, Spain : 1998)
|
April 5, 2008
Drospirenone/ethinyl estradiol
Andrea J Rapkin, Shelley N Sorger, Sharon A Winer
Contraception
|
October 20, 2023
Comparison of estrogenic components used for hormonal contraception
Frank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, et al.
Case Reports in Obstetrics and Gynecology
|
June 9, 2021
Successful Vaginal Delivery after External Cephalic Version in a Woman with a Large Partial Uterine Septum
Kristen E Park, Nicole L Vestal, Michael S Awadalla, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 1, 2009
Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness
Andrea J Rapkin, Sharon A Winer
The Journal of Reproductive Medicine
|
June 1, 2006
Premenstrual disorders: prevalence, etiology and impact
Sharon A Winer, Andrea J Rapkin
Expert Opinion on Pharmacotherapy
|
May 3, 2007
Drospirenone: a novel progestin
Andrea J Rapkin, Sharon A Winer
Menopause (New York, N.Y.)
|
April 26, 2013
Effect of hormone therapy on breast epithelial cell proliferation
Frank Z Stanczyk, Sharon A Winer
Expert Opinion on Pharmacotherapy
|
January 29, 2008
The pharmacologic management of premenstrual dysphoric disorder
Andrea J Rapkin, Sharon A Winer
Women'S Health (London, England)
|
October 7, 2009
Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder
Andrea J Rapkin, Michelle McDonald, Sharon A Winer
Menopause (New York, N.Y.)
|
May 27, 2025
Letters to the Editor
Frank Z Stanczyk, Sharon A Winer, Donna Shoupe
Drugs of Today (Barcelona, Spain : 1998)
|
April 5, 2008
Drospirenone/ethinyl estradiol
Andrea J Rapkin, Shelley N Sorger, Sharon A Winer
Contraception
|
October 20, 2023
Comparison of estrogenic components used for hormonal contraception
Frank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, et al.
Case Reports in Obstetrics and Gynecology
|
June 9, 2021
Successful Vaginal Delivery after External Cephalic Version in a Woman with a Large Partial Uterine Septum
Kristen E Park, Nicole L Vestal, Michael S Awadalla, et al.
Page
of 2